KLC
IONS icon

Knowledge Leaders Capital’s Ionis Pharmaceuticals IONS Stock Holding History

Knowledge Leaders Capital’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-19,360
Closed -$856K – 114
2022
Q3 		$856K Sell
19,360
-15,280
-44% -$644K 1.09% 22
2022
Q2 		$1.28M Buy
+34,640
New +$1.31M 1.24% 16
2020
Q4 		– Sell
-5,578
Closed -$265K – 121
2020
Q3 		$265K Buy
5,578
+71
+1% +$3.94K 0.25% 105
2020
Q2 		$325K Buy
+5,507
New +$306K 0.33% 99

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Knowledge Leaders Capital's IONS Position: Q4 2022 in Review

Knowledge Leaders Capital sold out of Ionis Pharmaceuticals (IONS) in Q4 2022, closing a stake of 19,360 shares — an estimated $856K sold.

Knowledge Leaders Capital first reported a position in IONS in Q2 2020 and held it in 4 quarters. The position peaked at $1.28M in Q2 2022. 338 funds tracked by Wall St. Rank hold IONS as of Q4 2022.

  • Knowledge Leaders Capital reported no remaining Ionis Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Knowledge Leaders Capital sold 19,360 Ionis Pharmaceuticals shares in Q4 2022, an estimated $856K.
  • Knowledge Leaders Capital first reported a position in Ionis Pharmaceuticals in Q2 2020 and held it in 4 quarters.
  • Knowledge Leaders Capital's Ionis Pharmaceuticals position peaked at $1.28M in Q2 2022.
  • 338 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2022.

Based on Knowledge Leaders Capital's 13F filing for Q4 2022, filed 7 Feb 2023.